Jane Street’s United Therapeutics UTHR Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | $30M | Buy |
55,400
+1,100
| +2% | +$620K | ﹤0.01% | 1794 |
|
|
2026
Q1 | $32.2M | Sell |
54,300
-51,900
| -49% | -$25.8M | ﹤0.01% | 1377 |
|
|
2025
Q4 | $51.7M | Sell |
106,200
-91,900
| -46% | -$42.8M | 0.01% | 923 |
|
|
2025
Q3 | $83M | Buy |
198,100
+191,400
| +2,857% | +$64.4M | 0.01% | 678 |
|
|
2025
Q2 | $1.93M | Buy |
6,700
+4,400
| +191% | +$1.31M | ﹤0.01% | 4481 |
|
|
2025
Q1 | $709K | Buy |
2,300
+1,400
| +156% | +$480K | ﹤0.01% | 6212 |
|
|
2024
Q4 | $318K | Sell |
900
-15,700
| -95% | -$5.77M | ﹤0.01% | 7639 |
|
|
2024
Q3 | $5.95M | Sell |
16,600
-397,700
| -96% | -$134M | ﹤0.01% | 2584 |
|
|
2024
Q2 | $132M | Sell |
414,300
-209,200
| -34% | -$55.4M | 0.03% | 313 |
|
|
2024
Q1 | $143M | Buy |
623,500
+605,300
| +3,326% | +$137M | 0.03% | 289 |
|
|
2023
Q4 | $4M | Buy |
18,200
+7,000
| +63% | +$1.61M | ﹤0.01% | 3180 |
|
|
2023
Q3 | $2.53M | Buy |
11,200
+6,100
| +120% | +$1.41M | ﹤0.01% | 3651 |
|
|
2023
Q2 | $1.13M | Sell |
5,100
-57,900
| -92% | -$12.8M | ﹤0.01% | 5025 |
|
|
2023
Q1 | $14.1M | Buy |
63,000
+800
| +1% | +$197K | 0.01% | 1291 |
|
|
2022
Q4 | $17.3M | Buy |
62,200
+37,100
| +148% | +$9.37M | 0.01% | 1115 |
|
|
2022
Q3 | $5.25M | Buy |
25,100
+19,100
| +318% | +$4.27M | ﹤0.01% | 2541 |
|
|
2022
Q2 | $1.41M | Sell |
6,000
-57,900
| -91% | -$11.8M | ﹤0.01% | 4826 |
|
|
2022
Q1 | $11.5M | Buy |
63,900
+55,000
| +618% | +$10.5M | ﹤0.01% | 1825 |
|
|
2021
Q4 | $1.92M | Sell |
8,900
-12,000
| -57% | -$2.36M | ﹤0.01% | 4578 |
|
|
2021
Q3 | $3.86M | Sell |
20,900
-2,100
| -9% | -$414K | ﹤0.01% | 3173 |
|
|
2021
Q2 | $4.13M | Sell |
23,000
-10,700
| -32% | -$2.04M | ﹤0.01% | 2983 |
|
|
2021
Q1 | $5.64M | Buy |
33,700
+20,800
| +161% | +$3.47M | ﹤0.01% | 2242 |
|
|
2020
Q4 | $1.96M | Buy |
12,900
+6,100
| +90% | +$801K | ﹤0.01% | 3520 |
|
|
2020
Q3 | $687K | Sell |
6,800
-4,600
| -40% | -$505K | ﹤0.01% | 4679 |
|
|
2020
Q2 | $1.38M | Buy |
+11,400
| New | +$1.28M | ﹤0.01% | 3600 |
|
|
2016
Q3 | – | Sell |
-18,600
| Closed | -$1.97M | – | 4569 |
|
|
2016
Q2 | $1.97M | Buy |
+18,600
| New | +$2.07M | 0.01% | 1286 |
|
|
2015
Q4 | – | Sell |
-39,700
| Closed | -$5.21M | – | 4502 |
|
|
2015
Q3 | $5.21M | Buy |
+39,700
| New | +$6.37M | 0.03% | 435 |
|
Other funds holding UTHR
ACA
JT
Jane Street's UTHR Position: Q2 2026 in Review
Jane Street increased its United Therapeutics (UTHR) stake by 10,263% in Q2 2026, buying an estimated $159M and bringing the position to 285,926 shares worth $155M. The position accounts for 0.01% of the portfolio, ranked #701.
Jane Street first reported a position in UTHR in Q3 2013 and has held it in 43 quarters since. 881 funds tracked by Wall St. Rank hold UTHR as of Q2 2026.
- Jane Street held 285,926 shares of United Therapeutics worth $155M as of Q2 2026.
- Jane Street bought 283,167 United Therapeutics shares in Q2 2026, an estimated $159M.
- United Therapeutics made up 0.01% of Jane Street's portfolio in Q2 2026, its #701 holding.
- Jane Street first reported a position in United Therapeutics in Q3 2013 and has held it in 43 quarters since.
- 881 funds tracked by Wall St. Rank held United Therapeutics as of Q2 2026.
Based on Jane Street's 13F filing for Q2 2026, filed 14 Aug 2026.